PUBLISHER: Grand View Research | PRODUCT CODE: 1679419
PUBLISHER: Grand View Research | PRODUCT CODE: 1679419
The global large and small-scale bioprocessing market size was valued at USD 80.5 billion in 2024 and is expected to grow at a CAGR of 13.8% from 2025 to 2030. Bioprocess engineering has been effectively explored for the development of biopharmaceuticals, and it has provided bio manufacturers and contract manufacturing organizations (CMOs) with lucrative avenues of growth. This, in turn, is expected to attract focused efforts to bolster the market adoption of various bioprocess engineering solutions.
Large Scale Bioprocessing involves the production of biopharmaceuticals and other biological products on a massive scale, typically using large bioreactors and extensive facilities. Whereas, small scale bioprocessing focuses on smaller batches, often utilizing micro-bioreactors and flexible systems for more precise control over production conditions. Both scales are crucial for meeting diverse market demands, from mass-produced vaccines to personalized medicines. The demand for biopharmaceuticals is a significant driver of this market, as these products offer targeted therapies for chronic diseases such as cancer and diabetes. This increasing demand fuels investments in technologies such as advanced incubation systems and filtration devices, ensuring that bioprocessing systems can scale efficiently while maintaining regulatory compliance.
As bioprocessing technologies evolve, manufacturers are adopting innovative solutions to enhance efficiency, reduce costs, and improve product quality. Technological advancements, including single-use technologies and automation, play a pivotal role in driving market growth. These innovations enable more efficient and cost-effective production methods, enhance process control, and minimize contamination risks. Furthermore, the shift towards personalized medicine necessitates scalable bioprocessing solutions that can adapt to smaller batch sizes without compromising quality. This customization trend positions the bioprocessing market for robust growth.
Rising investments in biotechnology research also significantly boost the market. Governments and private sectors are directing substantial funding towards biotechnological innovations, promoting collaborations between academic institutions, research organizations, and industry players. For instance, according to the UK Bio industy Association (BIA), UK biotechnology grant funding is expected to grow in 2025/2026. The Biotech and Medical sector received approximately over USD 160 million for R&D and over USD 50 million for capital investments in equipment. Innovation funding experienced a five-fold is projected to reach over USD 1 billion, focusing on under-funded regions and sectors undergoing digitalization such as healthcare.
The UK government plans to enhance innovation and economic growth via targeted incentives. This surge in funding supports the development of advanced bioprocessing techniques and facilities, driving substantial growth in the coming years. As more resources are allocated towards enhancing bioprocessing infrastructures, the market is poised to expand further, driven by the interplay of technological advancements, increasing demand for biopharmaceuticals, and strategic investments in research and development.
Global Large And Small-scale Bioprocessing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global large and small-scale bioprocessing market report based on scale, workflow, product, application, use type, mode, and region: